Qube Research & Technologies LTD Kronos Bio, Inc. Transaction History

Qube Research & Technologies LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$1.02 - $1.3 $1,608 - $2,050	-1,577 Reduced 84.15%	297 $0
Q4 2023 Feb 13, 2024	SELL	$0.75 - $1.49 $3,637 - $7,226	-4,850 Reduced 72.13%	1,874 $2,000
Q3 2023 Nov 13, 2023	SELL	$1.23 - $2.25 $64,832 - $118,595	-52,709 Reduced 88.69%	6,724 $8,000
Q2 2023 Aug 14, 2023	BUY	$1.24 - $1.92 $73,696 - $114,111	59,433 New	59,433 $102,000
Q3 2021 Nov 12, 2021	SELL	$18.17 - $24.7 $161,931 - $220,126	-8,912 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$20.08 - $29.02 $47,629 - $68,835	-2,372 Reduced 21.02%	8,912 $213,000
Q1 2021 May 14, 2021	BUY	$27.0 - $32.48 $304,668 - $366,504	11,284 New	11,284 $330,000

19.8M

9.3K

100

Ticker KRON
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,769,100
Market Cap $51.1M
Description
Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.